How You Can Help?
It takes tremendous resources to do what we do.
That's why, in 1991, a group of our patients established The Fund
for Research and Progress in Urology, an endowed fund whose sole aim is
to help ensure the future of discovery in the field of prostate cancer
here at the Brady Urological Institute.
This institute, the world's leading center for research and discovery
in prostate cancer, combines the talents of five full-time Ph.D.
scientists and world-renowned surgeons and medical oncologists
working with a team of postdoctoral fellows, residents in training,
and technical support staff. The Brady Urological Institute is a
four-story, free-standing institute of the Johns Hopkins Medical
Institutions, containing three floors of laboratories
dedicated to prostate cancer research. The support necessary
to maintain this mission totaled $4 million in fiscal year 1996.
Ideally the government, realizing the significance of what we're trying to do --
and what we've already accomplished -- would provide the funds necessary to
continue this mission. However, today more scientists than ever are competing
for support from the National Institutes of Health, even as its total
available research funds are diminishing. Although the backbone of our
funding -- one half ($2 million) -- comes from the NIH, these grants
don't provide everything necessary for the research environment. For
example, they don't pay for purchases of major equipment, some salaries,
and financial stability between grant periods, so the Brady has the hard
money needed to retain the most talented scientists and support personnel
in the country.
Another 25 percent of our funding comes from professional fees. Our
physicians receive a salary; this enables us to reinvest all extra
revenue in discovery. However, with the recent dramatic changes in
health care financing, the availability of funds from professional
fees is disappearing. Managed-care companies are siphoning off the
profit we once used to support this work and providing reimbursements
that are less than it costs to provide the kind of care we give. For
this reason, we can't depend on third-party reimbursements to support
our work in the way they once did.
Currently, the remaining 25 percent of our research budget comes from
our endowment, The Fund for Research and Progress in Urology.
With the growing demand for NIH support and diminishing availability of
funds from professional fees, it's increasingly important that we build
this endowment to safeguard the future of our mission of research and
There is so much hope in prostate cancer -- just take a look at the stories
that fill these pages. New discoveries are being made here every day.
But we're all too aware that we're fighting the clock. Although the
future is brighter than it has ever been, the present is still not ideal
for men with advanced prostate cancer. This disease kills one man in
the United States every 15 minutes. To reduce deaths from prostate cancer,
we need a four-pronged approach: Prevention, early detection, effective
treatment of localized disease, and better ways to contain advanced
disease. Our laboratories and our clinic are aggressively exploring
all of these.
Together, we can save lives. Your gift will help us beat this disease.
For more information on how you can make a tax-deductible contribution
to The Fund for Research and Progress in Urology of the Johns Hopkins
University, please call Alison Traub, Director of Development, at